Acute Lung Injury (ALI) Associated With COVID-19

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Lung Injury (ALI) Associated With COVID-19 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT04402866

TD-0903 for ALI Associated With COVID-19

This Phase 2 study will evaluate the efficacy, safety, pharmacodynamics and pharmacokinetics of inhaled TD-0903 compared with a matching placebo in combination…

United States235 participantsStarted 2020-06-24

Treatment: TD-0903, Placebo

CompletedPhase 1

NCT04350736

First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

This is a phase 1 study in healthy subjects to evaluate the safety, tolerability and pharmacokinetics of single (Part A and B) and multiple (Part B) doses of in…

United Kingdom54 participantsStarted 2020-04-23

Treatment: TD-0903, Placebo